PANCREATIC CANCER METASTATIC
Clinical trials for PANCREATIC CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CANCER METASTATIC trials appear
Sign up with your email to follow new studies for PANCREATIC CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets tough cancers in groundbreaking trial
Disease control Recruiting nowThis study is testing whether a new oral drug called TNG462 is safe and effective when combined with other cancer drugs for people with advanced pancreatic or non-small cell lung cancer. The trial will involve about 183 adults whose cancers have specific genetic changes (MTAP los…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Tango Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for pancreatic cancer patients in global drug trial
Disease control Recruiting nowThis study is testing whether a new drug called daraxonrasib, given alone or with standard chemotherapy, works better than chemotherapy alone for people with advanced pancreatic cancer that has spread. About 900 participants will be randomly assigned to receive one of three treat…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE3 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for tough cancer: experimental drug joins forces with standard chemo
Disease control Recruiting nowThis study is testing whether adding a new oral drug called narmafotinib to a standard chemotherapy regimen (mFOLFIRINOX) is safe and effective for people with metastatic pancreatic cancer. The first part finds a safe dose, and the second part tests two doses in more people to pi…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Amplia Therapeutics Limited • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Tiny 'Dream Vectors' target deadly pancreatic tumors in new trial
Disease control Recruiting nowThis study is testing whether adding a new experimental treatment to standard chemotherapy helps people with advanced pancreatic cancer that has worsened after initial therapy. The experimental treatment uses tiny 'nanocells' designed to deliver chemotherapy directly to cancer ce…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Engeneic Pty Limited • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New 'Off-the-Shelf' cell therapy trial offers hope for tough cancers
Disease control Recruiting nowThis study is testing a new type of treatment called EBNK-001, which uses donated immune cells (Natural Killer cells) to fight cancer. It is for adults with advanced solid tumors that have grown or returned after standard treatments. The main goals are to find a safe dose and see…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Essen Biotech • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Virus teams up with drug to fight tough stomach and pancreatic cancers
Disease control Recruiting nowThis study is testing a new two-part treatment for people with advanced or spreading cancers of the digestive system, like pancreatic or anal cancer. The treatment combines an engineered virus (pelareorep) with an immunotherapy drug (atezolizumab). Researchers want to see if this…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Oncolytics Biotech • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
New hope for pancreatic cancer patients: experimental treatment aims to extend survival
Disease control Recruiting nowThis study is testing whether a new formulation of paclitaxel chemotherapy (delivered in tiny particles called micelles) works better than the current standard treatment for metastatic pancreatic cancer. About 416 adults with newly diagnosed advanced pancreatic cancer will receiv…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE3 • Sponsor: Shanghai Yizhong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC
-
Needles vs. nausea: can ancient practice ease modern chemo side effects?
Symptom relief Recruiting nowThis study is testing whether adding acupuncture to standard anti-nausea medicine helps reduce nausea better for cancer patients undergoing chemotherapy. It will involve 90 patients who are already experiencing nausea despite taking their prescribed anti-sickness drugs. Participa…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: NA • Sponsor: Vejle Hospital • Aim: Symptom relief
Last updated Mar 02, 2026 15:23 UTC